Back to Search
Start Over
Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection.
- Source :
-
Jornal brasileiro de nefrologia [J Bras Nefrol] 2020 Aug 26; Vol. 42 (2 suppl 1), pp. 47-48. - Publication Year :
- 2020
-
Abstract
- This position statement of the Department of Hypertension of the Brazilian Society of Nephrology (SBN) addresses the controversy surrounding the use or suspension/replacement of the renin-angiotensin-aldosterone system blockers (particularly inhibitors of the angiotensin-converting enzyme or angiotensin II AT1 receptor blockers) prophylactically in individuals using these drugs, due to the possibility of allegedly worsening the prognosis of hypertensive patients infected with SARS-CoV-2. The SBN Hypertension Department recommends individualizing treatment and maintaining these medications until better scientific evidence is available.
- Subjects :
- Brazil
COVID-19
Humans
Nephrology
Pandemics
SARS-CoV-2
Withholding Treatment
Angiotensin II Type 1 Receptor Blockers therapeutic use
Angiotensin-Converting Enzyme Inhibitors therapeutic use
Betacoronavirus
Coronavirus Infections epidemiology
Hypertension drug therapy
Pneumonia, Viral epidemiology
Subjects
Details
- Language :
- English; Portuguese
- ISSN :
- 2175-8239
- Volume :
- 42
- Issue :
- 2 suppl 1
- Database :
- MEDLINE
- Journal :
- Jornal brasileiro de nefrologia
- Publication Type :
- Academic Journal
- Accession number :
- 32877500
- Full Text :
- https://doi.org/10.1590/2175-8239-JBN-2020-S112